SUB-TYPE: FIELD SAFETY NOTICE
The product recall for the affected batch is due to the incorrect shipment of products intended for the Belgian market to the UK/Ireland markets. As a result part of the shipments for batch 520 of Artelac Rebalance contain products with German/French/Dutch labelling. The labelling and Instructions for Use should be understood by all users in their country official language. Therefore German/French/Dutch labelled products must not be distributed in UK or Ireland
MHRA drug alert link: N/A
Pip code | Product description | Supplier | Batch numbers |
3620549 | ARTELAC REBALANCE 10ML | BAUSCH & LOMB | LOT 520 |
If you have any questions, please contact Bausch + Lomb Customer Service.
Email: Pharma_CS@bausch.com
Phone: 0845 602 2350
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
If you have any questions, then please contact your local Service Centre Customer Services team.
SUB-TYPE: CLASS 2 RECALL
AstraZeneca UK Limited is recalling the below batch of Bricanyl 0.5mg/ml solution for injection or infusion as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing
Pip code | Product description | Supplier | Batch Numbers |
0035188 | BRICANYL AMP 0.5MG/1ML | ASTRAZENECA | F1029-1 |
Please note that Alliance Healthcare do not stock and we are therefore not accepting stock returns.
For more information or medical information queries please contact
Tel: +44 (0) 0800 783 0033
Email: medical.informationuk@astrazeneca.com
For supply queries, please contact
Tel: +44 (0) 800 783 0033 (option 1)
Email: supply.chain@astrazeneca.com.
SUB-TYPE: FIELD SAFETY NOTICE
: B. Braun have detected new additional batches where the adhesive could not polymerize completely after its application. The tested products did not show the normal curing behaviour, providing lower adhesive forces than expected.
MHRA drug alert link: N/A
Pip code | Product description | Supplier | Batch numbers | |||||||||||||||||
0416024 | HISTOACRYL ADH TISSUE BLU | BRAUN B MEDICAL |
|
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
If you have any questions, then please contact your local Service Centre Customer Services team
SUB-TYPE: CLASS 4 CAUTION IN USE
: Lupin Healthcare (UK) Limited has informed us of a discrepancy with the product packaging for several batches of Syonell 250mg Gastro-Resistant Tablets and Syonell 500mg Gastro-Resistant Tablets. This discrepancy relates to the incorrect amount of active pharmaceutical ingredient (valproate semisodium) printed on the outer packaging
Pip code | Product description | Supplier | Batch Numbers |
4140760 | VALPROIC ACID (SYONELL) 250MG | LUPIN HEALTHCARE (UK) LTD | PLEASE FOLLOW MHRA LINK |
4140778 | VALPROIC ACID (SYONELL) 500MG | LUPIN HEALTHCARE (UK) LTD | PLEASE FOLLOW MHRA LINK |
This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.
This is a caution in use only we are not accepting stock returns.
For more information or medical information queries, please contact: +44 (0) 1565 751 378 Option 1 or Pharmacovigilance Department at EU-PV@lupin.com
For stock control queries, please contact: 44 (0) 1565 751 378 Option 2 or information@lupin.com
If you have any questions, then please contact your local Service Centre Customer Services team.
SUB-TYPE: CLASS 2 RECALL
The recall of SMA Wysoy is a food safety recall due to potential presence of foreign bodies (pieces of plastic scoops). Nestlé has undertaken it on a voluntary basis.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batches |
4086567 | SMA WYSOY SOYA INFANT FORMULA 800G | NESTLE NUTRITION (MOV) | 024957651Z 015757651Z 000957651Z 928957651Z 923357651Z |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies
SUB-TYPE: COMPANY-LED RECALL
The recall of SMA Wysoy is a food safety recall due to potential presence of foreign bodies (pieces of plastic scoops). Nestlé has undertaken it on a voluntary basis.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batches |
4086567 | SMA WYSOY SOYA INFANT FORMULA 800G | NESTLE NUTRITION (MOV) | 025057651Z 025057652Z 025157651Z |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies
SUB-TYPE: CLASS 4 CAUTION IN USE
Macarthys Laboratories Limited T/A Martindale Pharma has informed us that the EAN barcode on the outer carton of the above batch is incorrect. When scanned, the incorrect barcode shows the batch as Martindale Pharma’s Methylthioninium Chloride Injection 1% 10 X 10ml, which has been discontinued. All other information on the outer carton (including the 2D code), as well as the immediate packaging, is correct.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
ALLIANCE DO NOT STOCK | CAFFEINE CITRATE 10MG/ML SOLUTION FOR INJECTION | MACARTHYS LABORATORIES LIMITED T/A MARTINDALE PHARMA | 0134161 |
Please note that Alliance Healthcare do not stock and we are not accepting stock returns.
For more information or medical information queries, please contact: medinfo@ethypharm.co.uk
For stock control queries, please contact: Alan.josiah@ethypharm.com
SUB-TYPE: FIELD SAFETY NOTICE
Intersurgical Ltd have received complaints where a product that should contain an Adult EcoliteTM Aerosol Mask with vents/exhalation ports, has been found to contain a similar mask without vents/exhalation ports, this would prevent the patient breathing normally. If a mask without vents/exhalation ports is not identified and subsequently used on a patient, in situations where the patient cannot or does not remove the mask themselves this could result in distress, harm or potential fatality. It would also prevent the intended treatment being provided to the patient.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
0823484 | CIRRUS2 NEBULISER, ADULT, INTERSURGICAL ECOLITE MASK KIT WITH TUBE, 2.1M, 1453015 | INTERSURGICAL LTD | 32053274 32052973 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
This Field Safety Notice will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 16/06/2021. Please note after this date customer returns may still be accepted but customers may not be credited.
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
If you have any questions, then please contact your local Service Centre Customer Services team
SUB-TYPE: CLASS 3 RECALL
Thame Laboratories are recalling the above batches due to an issue with the container closure (child-resistant cap). The Marketing Authorisation Holder has received a number of complaints regarding the child-resistant caps which were difficult to open, and their investigation has identified an issue with the bottle capping process during the manufacture of the product.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
8073249 | ITRACONAZOLE 10MG/ML ORAL SOLUTION 150ML | THAME LABORATORIES | L465 L475 |
1216670 | ITRACONAZOLE 10MG/ML ORAL SOLUTION 150ML | THAME LABORATORIES | L465 L475 |
For more information or medical information queries, please contact customer.services@syrimed.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
This recall will remain open for 3 months from the date issued unless an alternative date is agreed by instigator. The closure of this will be 15/06/2021. Please note after this date customer returns may still be accepted but customers may not be credited.
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
If you have any questions, then please contact your local service centre customer service team.
SUB-TYPE: CLASS 4 CAUTION IN USE
Accord-UK Ltd have informed us that important safety warnings for the excipient Propylene glycol are missing from the patient information leaflet (PIL) used in the above batches(including the batches waiting QP certification) which should be present in accordance with the current annex to the Excipient Guidelines. Additionally, the warnings for sorbitol need updating although similar warnings are already present. The product is not subject to recall due to supply and shortage considerations
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
1059633 | DIAZEPAM SF SOLN 2MG/5ML ACC (100ML) | ACCORD-UK LTD | I54655 I54797 I54798 I55223 I55399 I55506 I55623 I55894 I56131 I56055 I56132 |
1202613 | DIAZEPAM SF SOLN 2MG/5ML ALM (100ML) | ALMUS | I54468 I54799 I55408 I55624 |
Alliance healthcare do not stock this product therefore we are not accepting stock returns.
For more information or medical information queries, please contact:
Accord-UK Ltd Medical Information Department on 01271 385257
For stock control queries, please contact: Accord-UK Ltd Customer Services Team on 0800 373573
Recipients of this Drug Alert should bring it to the attention of relevant contacts.